Thrombosis and Haemostasis Archive: Schattauer GmbH Verlag für Medizin und Naturwissenschaften

Indicator

Free Access

No Access

Partial Access

2008: 100/6 (Dec) pp. 955-1217

Journal:	Thrombosis and Haemostasis
ISSN:	0340-6245

Archive

Issue

44 articles

	1.	Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: Is clopidogrel any safer than aspirin when combined with warfarin?
		Kok Hoon Tay; Deirdre A. Lane; Gregory Y. H. Lip Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, United Kingdom Thrombosis and Haemostasis 2008 100 6: 955-957 http://dx.doi.org/10.1160/TH08-10-0685
		[Summary] [Free download]

	2.	Difference between sepsis and trauma diagnosed as sensitive diagnostic criteria for disseminated intravascular coagulation
		Hideo Wada1; Tsuyoshi Hatada2 1Department of Molecular and Laboratory Medicine, Me University Graduate School of Medicine, Mie, Japan; 2Department of Emergency Medicine, Me University Graduate School of Medicine, Mie, Japan Thrombosis and Haemostasis 2008 100 6: 958-959 http://dx.doi.org/10.1160/TH08-10-0683
		[Summary] [Free download]

	3.	Leptin, obesity and platelet responsiveness: Another piece in the puzzle
		Andrea Corsonello1; Francesco Corica2 1Istituto Nazionale di Ricovero e Cura per Anziani (INRCA), Cosenza, Italy; 2Dipartimento di Medicina Interna, Università degli Studi di Messina, Messina, Italy Thrombosis and Haemostasis 2008 100 6: 960-961 http://dx.doi.org/10.1160/TH08-10-0680
		[Summary] [Free download]

	4.	Predicting thrombotic events: Creating a complex approach for a complex condition
		Eduard Shantsila; Gregory Y. H. Lip Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, England, UK Thrombosis and Haemostasis 2008 100 6: 962-964 http://dx.doi.org/10.1160/TH08-10-0681
		[Summary] [Free download]

	5.	Plasminogen activator inhibitor-1 (PAI-1): A molecule at the crossroads to cell survival or cell death
		Thomas Kietzmann1; Peter Andreasen2 1Department of Chemistry/Biochemistry, University of Kaiserslautern, Kaiserslautern, Germany; 2Department of Molecular and Structural Biology, Aarhus University, Aarhus, Denmark Thrombosis and Haemostasis 2008 100 6: 965-968 http://dx.doi.org/10.1160/TH08-11-0735
		[Summary] [Free download]

	6.	Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins
		Egbert K. O. Kruithof Division of Angiology and Hemostasis, University Hospital, Geneva, Switzerland Thrombosis and Haemostasis 2008 100 6: 969-975 http://dx.doi.org/10.1160/TH08-04-0269
		[Summary] [Free download]

	7.	Integration of non-SMAD and SMAD signaling in TGF-β1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells
		Rohan Samarakoon; Paul J. Higgins Center for Cell Biology and Cancer Research, Albany Medical College, Albany, New York, USA Thrombosis and Haemostasis 2008 100 6: 976-983 http://dx.doi.org/10.1160/TH08-05-0273
		[Summary] [Free download]

	8.	The ‘PAI-1 paradox’ in vascular remodelling
		Isabel Diebold; Damir Kraicun; Steve Bonello; Agnes Görlach Experimentelle Kinderkardiologie, Deutsches Herzzentrum München an der Technischen Universität München, Munich, Germany Thrombosis and Haemostasis 2008 100 6: 984-991 http://dx.doi.org/10.1160/TH08-08-0524
		[Summary] [Free download]

	9.	Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: Lessons from the liver
		Elitsa Y. Dimova; Thomas Kietzmann Department of Chemistry/Biochemistry, University of Kaiserslautern, Kaiserslautern, Germany Thrombosis and Haemostasis 2008 100 6: 992-1006 http://dx.doi.org/10.1160/TH08-07-0490
		[Summary] [Free download]

	10.	Transcriptional regulation of the plasminogen activator inhibitor type 1 – with an emphasis on negative regulation
		Yoshikuni Nagamine Friedrich Miescher Institute for Biomedical Research, Novartis Research Foundation, Basel, Switzerland Thrombosis and Haemostasis 2008 100 6: 1007-1013 http://dx.doi.org/10.1160/TH08-05-0294
		[Summary] [Free download]

	11.	Anti-apoptotic roles of plasminogen activator inhibitor-1 as a neurotrophic factor in the central nervous system
		Shinji Soeda1; Satoru Koyanagi2; Yukako Kuramoto1; Masahiko Kimura3; Masatoshi Oda1; Tomohiro Kozako1; Satoru Hayashida1; Hiroshi Shimeno1 1Department of Biochemistry, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan; 2Pharmaceutics, Division of Clinical Pharmacy, Department of Medico-Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan; 3Medical Informatics and Research Units, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan Thrombosis and Haemostasis 2008 100 6: 1014-1020 http://dx.doi.org/10.1160/TH08-04-0259
		[Summary] [Free download]

	12.	Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: Role of NFκB-dependent hypoxia-inducible factor-1α transcription
		Isabel Diebold; Talija Djordjevic; John Hess; Agnes Görlach Experimentelle Kinderkardiologie, Deutsches Herzzentrum München an der Technischen Universität München, Munich, Germany Thrombosis and Haemostasis 2008 100 6: 1021-1028 http://dx.doi.org/10.1160/TH08-07-0473
		[Summary] [Free download]

	13.	Plasminogen activator inhibitor-1: The double-edged sword in apoptosis
		Rashna D. Balsara; Victoria A. Ploplis W. M. Keck Center for Transgene Research, Department of Chemistry and Biochemistry, and Notre Dame Cancer Institute, University of Notre Dame, Indiana, USA Thrombosis and Haemostasis 2008 100 6: 1029-1036 http://dx.doi.org/10.1160/TH08-07-0427
		[Summary] [Free download]

	14.	The effect of plasminogen activator inhibitor type 1 on apoptosis
		David J. Schneider1; Yabing Chen2; Burton E. Sobel1 1Department of Medicine and the Cardiovascular Research Institute, University of Vermont, Burlington, Vermont, USA; 2Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA Thrombosis and Haemostasis 2008 100 6: 1037-1040 http://dx.doi.org/10.1160/TH08-04-0234
		[Summary] [Free download]

	15.	Regulation of programmed cell death by plasminogen activator inhibitor type 1 (PAI-1)
		Ulrik A. Lademann; Maria Unni Rømer Department of Disease Biology, Section for Biomedicine, Faculty of Life Sciences, University of Copenhagen, Frederiksberg C., Denmark Thrombosis and Haemostasis 2008 100 6: 1041-1046 http://dx.doi.org/10.1160/TH08-04-0266
		[Summary] [Free download]

	16.	[Add to basket] Bleeding complications in patients on anticoagulants who would have been disqualified for clinical trials
		Marcel Levi; Kees Hovingh Department of Internal Medicine, Academic Medical Centre F-4, Amsterdam, the Netherlands Thrombosis and Haemostasis 2008 100 6: 1047-1051 http://dx.doi.org/10.1160/TH08-08-0530
		[Summary] [PDF] [Pay per view]

	17.	[Add to basket] Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon
		Maarten Beinema1; Jacobus R. B. J. Brouwers2; Tom Schalekamp3; Bob Wilffert2 1Thrombosis Centre, Deventer Hospital, Deventer, The Netherlands; 2Department of Pharmacotherapy and Pharmaceutical Care, University of Groningen, Groningen, The Netherlands; 3Division of Pharmacoepidemiology and Pharmacotherapy, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands Thrombosis and Haemostasis 2008 100 6: 1052-1057 http://dx.doi.org/10.1160/TH08-04-0116
		[Summary] [PDF] [Pay per view]

	18.	[Add to basket] Multimerin 1 binds factor V and activated factorV with high affinity and inhibits thrombin generation
		Samira B. Jeimy1; Nola Fuller1; Subia Tasneem1; Kenneth Segers2; Alan R. Stafford3; Jeffrey I. Weitz3; Rodney M. Camire4; Gerry A. F. Nicolaes2; Catherine P. M. Hayward1 1Department of Pathology and Molecular Medicine, Health Sciences Center, McMaster University, Hamilton, Ontario, Canada; 2Cardiovascular Research Institute, Maastricht Department of Biochemistry, Maastricht University, Maastricht, The Netherlands; 3Department of Medicine, McMaster University and Henderson Research Centre, Hamilton, Ontario, Canada; 4Department of Pediatrics, Division of Hematology, Children’s Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA Thrombosis and Haemostasis 2008 100 6: 1058-1067 http://dx.doi.org/10.1160/TH08-05-0307
		[Summary] [PDF] [Pay per view]

	19.	[Add to basket] Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases
		Birgit A. Steppich; Isabell Seitz; Gabi Busch; Andreas Stein; Ilka Ott Deutsches Herzzentrum der Technischen Universität München, Munich, Germany Thrombosis and Haemostasis 2008 100 6: 1068-1075 http://dx.doi.org/10.1160/TH08-05-0293
		[Summary] [PDF] [Pay per view]

	20.	[Add to basket] Effect of oral antiplatelet agents on major bleeding in users of coumarins
		Tom Schalekamp; Olaf H. Klungel; Patrick C. Souverein; Anthonius de Boer Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands Thrombosis and Haemostasis 2008 100 6: 1076-1083 http://dx.doi.org/10.1160/TH08-05-0290
		[Summary] [PDF] [Pay per view]